Skip to content

Drug interactions

Lapatinib + Sonidegib

Severity: Moderate

Lapatinib and Sonidegib: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Sonidegib is metabolized mainly by CYP3A4, and lapatinib is a weak CYP3A4 inhibitor. Raised sonidegib levels could increase the risk of musculoskeletal toxicity such as myopathy and creatine kinase elevation.

What this interaction means in plain words

Lapatinib and Sonidegib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Lapatinib belongs to Oncology; Sonidegib belongs to Oncology.

Evidence level: Low

Why it happens

Lapatinib inhibits CYP3A4, decreasing the clearance of sonidegib.

What to do

Monitor for muscle pain, weakness and creatine kinase elevation. Interrupt or stop sonidegib if significant musculoskeletal toxicity develops.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Lapatinib and Sonidegib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Lapatinib with Sonidegib?

MediHelp rates the interaction as moderate. Lapatinib and Sonidegib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Sonidegib is metabolized mainly by CYP3A4, and lapatinib is a weak CYP3A4 inhibitor. Raised sonidegib levels could increase the risk of musculoskeletal toxicity such as myopathy and creatine kinase elevation.

How serious is the interaction between Lapatinib and Sonidegib?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor for muscle pain, weakness and creatine kinase elevation. Interrupt or stop sonidegib if significant musculoskeletal toxicity develops.

What other medicines interact with Lapatinib?

MediHelp also lists interactions of Lapatinib with, for example, Dofetilide, Ibutilide, Pimozide. The full list is on the Lapatinib page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in